Načítá se...
HSF1 as a Cancer Biomarker and Therapeutic Target
Heat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat shock response. In this classical role, HSF1 is activated following cellular stresses such as heat shock that ultimately lead to HSF1-mediated expression of heat shock proteins to protect the proteome and survive t...
Uloženo v:
| Vydáno v: | Curr Cancer Drug Targets |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6472998/ https://ncbi.nlm.nih.gov/pubmed/30338738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1568009618666181018162117 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|